BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 26449403)

  • 1. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
    Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
    Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
    Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
    Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
    Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
    Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury.
    Moss NC; Stansfield WE; Willis MS; Tang RH; Selzman CH
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2248-53. PubMed ID: 17675566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
    Qian W; Zhao C; Li D; Dai R
    Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.
    Takatori O; Usui S; Okajima M; Kaneko S; Ootsuji H; Takashima SI; Kobayashi D; Murai H; Furusho H; Takamura M
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):283-292. PubMed ID: 27909014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.
    De Hoog VC; Timmers L; Van Duijvenvoorde A; De Jager SC; Van Middelaar BJ; Smeets MB; Woodruff TM; Doevendans PA; Pasterkamp G; Hack CE; De Kleijn DP
    Cardiovasc Res; 2014 Sep; 103(4):521-9. PubMed ID: 24935433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor attenuates myocardial ischaemia-reperfusion injury possibly through downregulating galectin-3 expression in the infarct area of rats.
    Liu X; Gu Y; Liu Y; Zhang M; Wang Y; Hu L
    Br J Clin Pharmacol; 2018 Jun; 84(6):1180-1186. PubMed ID: 29381821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.
    Bhindi R; Fahmy RG; McMahon AC; Khachigian LM; Lowe HC
    J Pathol; 2012 Jun; 227(2):157-64. PubMed ID: 22344601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
    Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
    Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
    Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes.
    Chen S; Liu J; Liu X; Fu Y; Zhang M; Lin Q; Zhu J; Mai L; Shan Z; Yu X; Yang M; Lin S
    J Ethnopharmacol; 2011 Sep; 137(1):263-70. PubMed ID: 21619920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.